Effective treatment with mepolizumab in a patient with refractory Wells syndrome

J Dtsch Dermatol Ges. 2020 Jul;18(7):737-739. doi: 10.1111/ddg.14151.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Cellulitis / complications
  • Cellulitis / drug therapy*
  • Cellulitis / immunology
  • Cellulitis / pathology
  • Eosinophilia / complications
  • Eosinophilia / drug therapy*
  • Eosinophilia / immunology
  • Eosinophilia / pathology
  • Eosinophils / metabolism
  • Humans
  • Injections, Subcutaneous
  • Interleukin-5 / antagonists & inhibitors
  • Interleukin-5 / immunology
  • Male
  • Pruritus / etiology
  • Skin / pathology*

Substances

  • Antibodies, Monoclonal, Humanized
  • Interleukin-5
  • mepolizumab

Supplementary concepts

  • Wells syndrome